Compare PROF & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | SPOK |
|---|---|---|
| Founded | N/A | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.2M | 220.6M |
| IPO Year | 2017 | 2004 |
| Metric | PROF | SPOK |
|---|---|---|
| Price | $6.46 | $10.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $14.00 |
| AVG Volume (30 Days) | 65.9K | ★ 162.0K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 11.31% |
| EPS Growth | ★ 25.89 | 2.74 |
| EPS | ★ 0.19 | 0.09 |
| Revenue | $16,098,000.00 | ★ $139,708,000.00 |
| Revenue This Year | $92.40 | $1.70 |
| Revenue Next Year | $64.10 | N/A |
| P/E Ratio | ★ $35.11 | $120.00 |
| Revenue Growth | ★ 50.73 | 1.49 |
| 52 Week Low | $3.92 | $9.95 |
| 52 Week High | $8.95 | $19.31 |
| Indicator | PROF | SPOK |
|---|---|---|
| Relative Strength Index (RSI) | 41.47 | 48.97 |
| Support Level | $5.81 | $10.87 |
| Resistance Level | $7.07 | $11.55 |
| Average True Range (ATR) | 0.27 | 0.22 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 15.15 | 65.28 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.